BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Enobia Pharma 

2901, Rachel Street East, Suite 23

Montreal  Quebec    Canada
Phone: 514-596-2901 Fax: 514-596-2749


SEARCH JOBS


Industry
Biotechnology






 Company News
Alexion Pharmaceuticals Inc. (ALXN) Completes Acquisition of Enobia Pharma 2/7/2012 8:21:01 AM    More...
Alexion Pharmaceuticals Inc. (ALXN) to Host Conference Call This Morning to Discuss Company’s Proposed Acquisition of Enobia Pharma 12/29/2011 6:01:50 AM    More...
Alexion Pharmaceuticals Inc. (ALXN) to Pay $1 Billion for Enobia Pharma 12/29/2011 6:00:20 AM    More...
Enobia Pharma Raises US $40 Million 8/10/2011 6:34:39 AM    More...
Lonza Inc. Signs Commercial Manufacturing Deal with Enobia Pharma for Orphan Drug Candidate 3/15/2011 9:07:07 AM    More...
Enobia Pharma Announces Completion of Enrollment in Third Phase II Hypophosphatasia Study of ENB-0040, a Bone Targeted Enzyme Replacement Therapy 2/24/2011 10:09:19 AM    More...
Enobia Pharma Announces Successful Completion of Phase II Juvenile Study of ENB-0040, a Bone Targeted Enzyme Replacement Therapy 1/11/2011 7:03:23 AM    More...
Enobia Pharma Reports Positive Results For Phase II Trial of ENB-0040 in Juvenile Hypophosphatasia 9/24/2010 8:42:01 AM    More...
Enobia Pharma Provides Update on Progress With ENB-0040, a Bone-Targeted Enzyme Replacement Therapy for Hypophosphatasia 9/8/2010 12:14:50 PM    More...
Enobia Pharma: ENB-0040, a Bone Targeted Enzyme Replacement Therapy, Shows Promise in Children with Hypophosphatasia 6/21/2010 10:03:06 AM    More...
123

//-->